These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10551154)

  • 1. Protective effect of serum antibodies against a 110-kilodalton protein of Actinobacillus actinomycetemcomitans following periodontal therapy.
    Beikler T; Karch H; Ehmke B; Klaiber B; Flemmig TF
    Oral Microbiol Immunol; 1999 Oct; 14(5):281-7. PubMed ID: 10551154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis.
    Flemmig TF; Milián E; Karch H; Klaiber B
    J Clin Periodontol; 1998 May; 25(5):380-7. PubMed ID: 9650874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal infection with Actinobacillus actinomycetemcomitans following periodontal therapy.
    Ehmke B; Schmidt H; Beikler T; Kopp C; Karch H; Klaiber B; Flemmig TF
    J Dent Res; 1999 Sep; 78(9):1518-24. PubMed ID: 10512386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal dynamics of infection and serum antibody in A. actinomycetemcomitans periodontitis.
    Ebersole JL; Capelli D; Steffen MJ
    Oral Dis; 1995 Sep; 1(3):129-38. PubMed ID: 8705818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of systemic metronidazole and amoxicillin on Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in intraoral habitats.
    Flemmig TF; Milián E; Kopp C; Karch H; Klaiber B
    J Clin Periodontol; 1998 Jan; 25(1):1-10. PubMed ID: 9477013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific antibody reactivity against a 110-kilodalton Actinobacillus actinomycetemcomitans protein in subjects with periodontitis.
    Fleming TF; Selmair I; Schmidt H; Karch H
    Clin Diagn Lab Immunol; 1996 Nov; 3(6):678-81. PubMed ID: 8914758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen specificity of serum antibody in A. actinomycetemcomitans-infected periodontitis patients.
    Ebersole JL; Cappelli D; Sandoval MN; Steffen MJ
    J Dent Res; 1995 Feb; 74(2):658-66. PubMed ID: 7722063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of periodontal treatment on Aggregatibacter actinomycetemcomitans colonization and serum IgG levels against A. actinomycetemcomitans serotypes and Omp29 of aggressive periodontitis patients.
    Rebeis ES; Albuquerque-Souza E; Paulino da Silva M; Giudicissi M; Mayer MPA; Saraiva L
    Oral Dis; 2019 Mar; 25(2):569-579. PubMed ID: 30506613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gingival crevicular fluid antibody to Actinobacillus actinomycetemcomitans in periodontal disease.
    Ebersole JL; Cappelli D
    Oral Microbiol Immunol; 1994 Dec; 9(6):335-44. PubMed ID: 7870468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G subclass response of juvenile periodontitis subjects to principal outer membrane proteins of Actinobacillus actinomycetemcomitans.
    Wilson ME; Hamilton RG
    Infect Immun; 1995 Mar; 63(3):1062-9. PubMed ID: 7868228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attachment loss and serum antibody levels against autologous and reference strains of Actinobacillus actinomycetemcomitans in untreated localized juvenile periodontitis patients.
    Tinoco EM; Lyngstadaas SP; Preus HR; Gjermo P
    J Clin Periodontol; 1997 Dec; 24(12):937-44. PubMed ID: 9442433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and systemic immunoglobulin G-subclass antibodies to Actinobacillus actinomycetemcomitans leukotoxin.
    Engström PE; George M; Larsson P; Lally ET; Taichman NS; Norhagen G
    Oral Microbiol Immunol; 1999 Apr; 14(2):104-8. PubMed ID: 10219169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis.
    Müller HP; Heinecke A; Borneff M; Kiencke C; Knopf A; Pohl S
    J Periodontal Res; 1998 Jan; 33(1):49-58. PubMed ID: 9524321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunoglobulin G responses to various Actinobacillus actinomycetemcomitans serotypes in a young ethnographically heterogeneous periodontitis patient group.
    Gmür R; Baehni PC
    Oral Microbiol Immunol; 1997 Feb; 12(1):1-10. PubMed ID: 9151638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifactorial assessment of predictors for prevention of periodontal disease progression.
    Ehmke B; Beikler T; Haubitz I; Karch H; Flemmig TF
    Clin Oral Investig; 2003 Dec; 7(4):217-21. PubMed ID: 12942352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell envelope and cell wall immunization of Macaca fascicularis: effect on the progression of ligature-induced periodontitis.
    Holt SC; Brunsvold M; Jones A; Wood R; Ebersole JL
    Oral Microbiol Immunol; 1995 Dec; 10(6):321-33. PubMed ID: 8602339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody reactive with Actinobacillus actinomycetemcomitans leukotoxin in early-onset periodontitis patients.
    Califano JV; Pace BE; Gunsolley JC; Schenkein HA; Lally ET; Tew JG
    Oral Microbiol Immunol; 1997 Feb; 12(1):20-6. PubMed ID: 9151640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there specific benefits of amoxicillin plus metronidazole in Aggregatibacter actinomycetemcomitans-associated periodontitis? Double-masked, randomized clinical trial of efficacy and safety.
    Mombelli A; Cionca N; Almaghlouth A; Décaillet F; Courvoisier DS; Giannopoulou C
    J Periodontol; 2013 Jun; 84(6):715-24. PubMed ID: 22873656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitis.
    Nieminen A; Asikainen S; Torkko H; Kari K; Uitto VJ; Saxén L
    J Clin Periodontol; 1996 Jun; 23(6):572-81. PubMed ID: 8811478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibody reactivity against recombinant PrtC of Porphyromonas gingivalis following periodontal therapy.
    Beikler T; Ehmke B; Wittstock M; Schmidt H; Karch H; Flemmig TF
    J Periodontal Res; 2003 Jun; 38(3):276-81. PubMed ID: 12753365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.